Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks - Endpoints News
Sentiment Mix
Geography
Expert Signals
Politics - Google News US Headlines
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints NewsNature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce PharmaNature Medicine retracts Chinese lung cancer immunotherapy timing study 747 LivePaolo Tarantino: Nature Medicine Retracts Debated Study on Early Morning Immunotherapy Benefits OncodailyNature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day MedPage Today
Supported by 1 story
Related Events
Iran war: Trump cancels envoys' trip to Islamabad - DW.com
Research • 6/25/2026
Riding primary momentum, democratic socialists eye a battleground state breakthrough
Research • 6/26/2026
Weight-loss drug approved to treat sleep apnea in Canada - Radio-Canada
Uncategorized • 6/25/2026
New research out of Winnipeg could impact how brain bleeds are treated globally - Yahoo News Canada
Uncategorized • 6/25/2026
As Ebola Bundibugyo outbreak rages, knowledge gaps still challenge response - Reuters
Uncategorized • 6/25/2026